 | • レポートコード：20QY06-02427 • 出版社/出版日：QYResearch / 2020年6月1日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、137ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、デフェリプロンのグローバル市場について種類別（錠剤、経口液剤、カプセル剤）、用途別（輸血による鉄過剰、NTDTによる鉄過剰）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・デフェリプロン市場の概要 ・世界の主要地域別デフェリプロン市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のデフェリプロン市場規模2015-2026：種類別（錠剤、経口液剤、カプセル剤） ・世界のデフェリプロン市場規模2015-2026：用途別（輸血による鉄過剰、NTDTによる鉄過剰） ・デフェリプロンの北米市場規模2015-2020 ・デフェリプロンのヨーロッパ市場規模2015-2020 ・デフェリプロンの中国市場規模2015-2020 ・デフェリプロンの日本市場規模2015-2020 ・デフェリプロンの東南アジア市場規模2015-2020 ・デフェリプロンのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Apotex、Cipla） ・デフェリプロンの製造コスト分析 ・販売チャネル、流通業者、顧客 ・デフェリプロンの市場動向・機会・課題 ・調査の結論 |
Deferiprone is an orally bioavailable bidentate ligand with iron chelating activity.1 It binds to iron in a 3:1 (ligand:iron) molar ratio and, thereby, is able to remove excess iron from the body. Deferiprone has been investigated for clinical use in diseases of systemic iron overload.
The proportion of deferiprone tablet in 2016 is about 62.64%, while deferiprone capsule have a 26.76% market share.Deferiprone is widely applied in Transfusional Iron Overload and NTDT Caused Iron Overload. The most proportion of deferiprone is Transfusional Iron Overload and in 2016 with 79.42% market
North America is the largest consumption region of deferiprone, with a consumption value market share nearly 28.48% in 2016. Europe is the second largest consumption region of deferiprone, enjoying consumption value market share nearly 24.39% in 2016.Apotex, Cipla and other company are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
Market Analysis and Insights: Global Deferiprone Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Deferiprone market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Deferiprone industry.
Based on our recent survey, we have several different scenarios about the Deferiprone YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 34 million in 2019. The market size of Deferiprone will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
Global Deferiprone Scope and Market Size
The global Deferiprone market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Deferiprone market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Deferiprone market is segmented into
Tablet
Oral Solution
Capsule
Segment by Application, the Deferiprone market is segmented into
Transfusional Iron Overload
NTDT Caused Iron Overload
The Deferiprone market is analysed and market size information is provided by regions (countries). Segment by Application, the Deferiprone market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Deferiprone Market Share Analysis
Deferiprone market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Deferiprone business, the date to enter into the Deferiprone market, Deferiprone product introduction, recent developments, etc.
The major vendors covered:
Apotex
Cipla
…
1 Deferiprone Market Overview
1.1 Deferiprone Product Scope
1.2 Deferiprone Segment by Type
1.2.1 Global Deferiprone Sales by Type (2020-2026)
1.2.2 Tablet
1.2.3 Oral Solution
1.2.4 Capsule
1.3 Deferiprone Segment by Application
1.3.1 Global Deferiprone Sales Comparison by Application (2020-2026)
1.3.2 Transfusional Iron Overload
1.3.3 NTDT Caused Iron Overload
1.4 Deferiprone Market Estimates and Forecasts (2015-2026)
1.4.1 Global Deferiprone Sales Growth Rate (2015-2026)
1.4.2 Global Deferiprone Revenue and Growth Rate (2015-2026)
1.4.3 Global Deferiprone Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Deferiprone Industry Impact
1.5.1 How the Covid-19 is Affecting the Deferiprone Industry
1.5.1.1 Deferiprone Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Deferiprone Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Deferiprone Players to Combat Covid-19 Impact
2 Deferiprone Estimate and Forecast by Region
2.1 Global Deferiprone Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Deferiprone Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Deferiprone Sales Market Share by Region (2015-2020)
2.2.2 Global Deferiprone Revenue Market Share by Region (2015-2020)
2.3 Global Deferiprone Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Deferiprone Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Deferiprone Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Deferiprone Estimates and Projections (2015-2026)
2.4.2 Europe Deferiprone Estimates and Projections (2015-2026)
2.4.3 China Deferiprone Estimates and Projections (2015-2026)
2.4.4 Japan Deferiprone Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Deferiprone Estimates and Projections (2015-2026)
2.4.6 India Deferiprone Estimates and Projections (2015-2026)
3 Global Deferiprone Competition Landscape by Players
3.1 Global Top Deferiprone Players by Sales (2015-2020)
3.2 Global Top Deferiprone Players by Revenue (2015-2020)
3.3 Global Deferiprone Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Deferiprone as of 2019)
3.4 Global Deferiprone Average Price by Company (2015-2020)
3.5 Manufacturers Deferiprone Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Deferiprone Players (Opinion Leaders)
4 Global Deferiprone Market Size by Type
4.1 Global Deferiprone Historic Market Review by Type (2015-2020)
4.1.1 Global Deferiprone Sales Market Share by Type (2015-2020)
4.1.2 Global Deferiprone Revenue Market Share by Type (2015-2020)
4.1.3 Global Deferiprone Price by Type (2014-2020)
4.2 Global Deferiprone Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Deferiprone Sales Forecast by Type (2021-2026)
4.2.2 Global Deferiprone Revenue Forecast by Type (2021-2026)
4.2.3 Global Deferiprone Price Forecast by Type (2021-2026)
5 Global Deferiprone Market Size by Application
5.1 Global Deferiprone Historic Market Review by Application (2015-2020)
5.1.1 Global Deferiprone Sales Market Share by Application (2015-2020)
5.1.2 Global Deferiprone Revenue Market Share by Application (2015-2020)
5.1.3 Global Deferiprone Price by Application (2015-2020)
5.2 Global Deferiprone Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Deferiprone Sales Forecast by Application (2021-2026)
5.2.2 Global Deferiprone Revenue Forecast by Application (2021-2026)
5.2.3 Global Deferiprone Price Forecast by Application (2021-2026)
3 North America Deferiprone Market Facts & Figures
3.2 North America Deferiprone Sales Market Share by Company (2015-2020)
3.3 North America Deferiprone Sales Market Share by Type (2015-2020)
3.4 North America Deferiprone Sales Market Share by Application (2015-2020)
4 Europe Deferiprone Market Facts & Figures
4.2 Europe Deferiprone Sales Market Share by Company (2015-2020)
4.3 Europe Deferiprone Sales Market Share by Type (2015-2020)
4.4 Europe Deferiprone Sales Market Share by Application (2015-2020)
5 China Deferiprone Market Facts & Figures
5.2 China Deferiprone Sales Market Share by Company (2015-2020)
5.3 China Deferiprone Sales Market Share by Type (2015-2020)
5.4 China Deferiprone Sales Market Share by Application (2015-2020)
6 Japan Deferiprone Market Facts & Figures
6.2 Japan Deferiprone Sales Market Share by Company (2015-2020)
6.3 Japan Deferiprone Sales Market Share by Type (2015-2020)
6.4 Japan Deferiprone Sales Market Share by Application (2015-2020)
7 Southeast Asia Deferiprone Market Facts & Figures
7.2 Southeast Asia Deferiprone Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Deferiprone Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Deferiprone Sales Market Share by Application (2015-2020)
8 India Deferiprone Market Facts & Figures
8.2 India Deferiprone Sales Market Share by Company (2015-2020)
8.3 India Deferiprone Sales Market Share by Type (2015-2020)
8.4 India Deferiprone Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Deferiprone Business
12.1 Apotex
12.1.1 Apotex Deferiprone Corporation Information
12.1.2 Apotex Deferiprone Business Overview and Total Revenue
12.1.3 Apotex Deferiprone Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Apotex Deferiprone Products Offered
12.1.5 Apotex Recent Development
12.2 Cipla
12.2.1 Cipla Deferiprone Corporation Information
12.2.2 Cipla Deferiprone Business Overview and Total Revenue
12.2.3 Cipla Deferiprone Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Cipla Deferiprone Products Offered
12.2.5 Cipla Recent Development
…
13 Deferiprone Manufacturing Cost Analysis
13.1 Deferiprone Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Deferiprone
13.4 Deferiprone Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Deferiprone Distributors List
14.3 Deferiprone Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Deferiprone Sales (Kg) Growth Rate by Type (2020-2026)
Table 2. Global Deferiprone Sales (Kg) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Deferiprone Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Deferiprone Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Deferiprone Players to Combat Covid-19 Impact
Table 8. Global Market Deferiprone Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Deferiprone Sales (Kg) by Region (2015-2020)
Table 10. Global Deferiprone Sales Market Share by Region (2015-2020)
Table 11. Global Deferiprone Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Deferiprone Revenue Share by Region (2015-2020)
Table 13. Global Deferiprone Sales (Kg) Forecast by Region (2021-2026)
Table 14. Global Deferiprone Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Deferiprone Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Deferiprone Revenue Share Forecast by Region (2021-2026)
Table 17. Global Deferiprone (Kg) of Key Companies (2015-2020)
Table 18. Global Deferiprone Sales Share by Company (2015-2020)
Table 19. Global Deferiprone Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Deferiprone Revenue Share by Company (2015-2020)
Table 21. Global Deferiprone by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Deferiprone as of 2019)
Table 22. Global Deferiprone Average Price (USD/g) of Key Company (2015-2020)
Table 23. Manufacturers Deferiprone Manufacturing Sites and Area Served
Table 24. Manufacturers Deferiprone Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Deferiprone Players
Table 27. Global Deferiprone Sales (Kg) by Type (2015-2020)
Table 28. Global Deferiprone Sales Share by Type (2015-2020)
Table 29. Global Deferiprone Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Deferiprone Price (Kg) by Type (2015-2020)
Table 31. Global Deferiprone Sales Share by Type (2021-2026)
Table 32. Global Deferiprone Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Deferiprone Revenue Share by Type (2021-2026)
Table 34. Global Deferiprone Price (Kg) by Type (2021-2026)
Table 35. Global Deferiprone Sales (Kg) by Application (2015-2020)
Table 36. Global Deferiprone Sales Share by Application (2015-2020)
Table 37. Global Deferiprone Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Deferiprone Price (Kg) by Application (2015-2020)
Table 39. Global Deferiprone Sales (Kg) by Application (2021-2026)
Table 40. Global Deferiprone Sales Share by Application (2021-2026)
Table 41. Global Deferiprone Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Deferiprone Revenue Share by Application (2021-2026)
Table 43. Global Deferiprone Price (Kg) by Application (2021-2026)
Table 44. United States Deferiprone Sales (Kg) by Company (2015-2020)
Table 45. United States Deferiprone Sales Market Share by Company (2015-2020)
Table 46. United States Deferiprone Sales (Kg) by Type (2015-2020)
Table 47. United States Deferiprone Sales Market Share by Type (2015-2020)
Table 48. United States Deferiprone Sales (Kg) by Application (2015-2020)
Table 49. United States Deferiprone Sales Market Share by Application (2015-2020)
Table 50. Europe Deferiprone Sales (Kg) by Company (2015-2020)
Table 51. Europe Deferiprone Sales Market Share by Company (2015-2020)
Table 52. Europe Deferiprone Sales (Kg) by Type (2015-2020)
Table 53. Europe Deferiprone Sales Market Share by Type (2015-2020)
Table 54. Europe Deferiprone Sales (Kg) by Application (2015-2020)
Table 55. Europe Deferiprone Sales Market Share by Type (2015-2020)
Table 56. China Deferiprone Sales (Kg) by Company (2015-2020)
Table 57. China Deferiprone Sales Market Share by Company (2015-2020)
Table 58. China Deferiprone Sales (Kg) by Type (2015-2020)
Table 59. China Deferiprone Sales Market Share by Type (2015-2020)
Table 60. China Deferiprone Sales (Kg) by Application (2015-2020)
Table 61. China Deferiprone Sales Market Share by Application (2015-2020)
Table 62. Japan Deferiprone Sales (Kg) by Company (2015-2020)
Table 63. Japan Deferiprone Sales Market Share by Company (2015-2020)
Table 64. Japan Deferiprone Sales (Kg) by Type (2015-2020)
Table 65. Japan Deferiprone Sales Market Share by Type (2015-2020)
Table 66. Japan Deferiprone Sales (Kg) by Application (2015-2020)
Table 67. Japan Deferiprone Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Deferiprone Sales (Kg) by Company (2015-2020)
Table 69. Southeast Asia Deferiprone Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Deferiprone Sales (Kg) by Type (2015-2020)
Table 71. Southeast Asia Deferiprone Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Deferiprone Sales (Kg) by Type (2015-2020)
Table 73. Southeast Asia Deferiprone Sales Market Share by Application (2015-2020)
Table 74. India Deferiprone Sales (Kg) by Company (2015-2020)
Table 75. India Deferiprone Sales Market Share by Company (2015-2020)
Table 76. India Deferiprone Sales (Kg) by Type (2015-2020)
Table 77. India Deferiprone Sales Market Share by Type (2015-2020)
Table 78. India Deferiprone Sales (Kg) by Application (2015-2020)
Table 79. India Deferiprone Sales Market Share by Application (2015-2020)
Table 80. Apotex Corporation Information
Table 81. Apotex Description and Business Overview
Table 82. Apotex Deferiprone Sales (Kg), Revenue (Million USD), Price (USD/g) and Gross Margin (2015-2020)
Table 83. Apotex Deferiprone Product
Table 84. Apotex Recent Development
Table . Cipla Corporation Information
Table . Cipla Description and Business Overview
Table . Cipla Deferiprone Sales (Kg), Revenue (Million USD), Price (USD/g) and Gross Margin (2015-2020)
Table . Cipla Deferiprone Product
Table . Cipla Recent Development
Table 90. Production Base and Market Concentration Rate of Raw Material
Table 91. Key Suppliers of Raw Materials
Table 92. Deferiprone Distributors List
Table 93. Deferiprone Customers List
Table 94. Market Key Trends
Table 95. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 96. Key Challenges
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
List of Figures
Figure 1. Deferiprone Product Picture
Figure 2. Global Deferiprone Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Deferiprone Market Share by Application in 2020 & 2026
Figure 6. Transfusional Iron Overload Examples
Figure 7. NTDT Caused Iron Overload Examples
Figure 8. Global Deferiprone Sales (Kg) Growth Rate (2015-2026)
Figure 9. Global Deferiprone Revenue (US$ Million) Growth Rate (2015-2026)
Figure 10. Global Deferiprone Price Trends Growth Rate (2015-2026) (USD/g)
Figure 11. Global Deferiprone Revenue Market Share by Region: 2015 VS 2020
Figure 12. Global Deferiprone Revenue Market Share by Region: 2021 VS 2026
Figure 13. United States Deferiprone Revenue (Million USD) Growth Rate (2015-2026)
Figure 14. United States Deferiprone Sales (Kg) Growth Rate (2015-2026)
Figure 15. Europe Deferiprone Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. Europe Deferiprone Sales (Million USD) Growth Rate (2015-2026)
Figure 17. China Deferiprone Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. China Deferiprone Sales (Million USD) and Growth Rate (2015-2026)
Figure 19. Japan Deferiprone Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. Japan Deferiprone Sales (Million USD) Growth Rate (2015-2026)
Figure 21. Southeast Asia Deferiprone Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Deferiprone Sales (Million USD) Growth Rate (2015-2026)
Figure 23. India Deferiprone Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. India Deferiprone Sales (Million USD) Growth Rate (2015-2026)
Figure 25. Global 5 Largest Deferiprone Players Market Share by Revenue in Deferiprone 2015 & 2019
Figure 26. Deferiprone Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Deferiprone Revenue Share by Type (2015-2020)
Figure 28. Global Deferiprone Revenue Growth Rate by Type in 2015 & 2019
Figure 29. Global Deferiprone Revenue Share by Application (2015-2020)
Figure 30. Global Deferiprone Revenue Growth Rate by Application in 2015 & 2019
Figure 31. United States Deferiprone Sales Market Share by Type in 2019
Figure 32. United States Deferiprone Sales Market Share by Type in 2019
Figure 33. Europe Deferiprone Sales Market Share by Company in 2019
Figure 34. Europe Deferiprone Sales Market Share by Type in 2019
Figure 35. Europe Deferiprone Sales Market Share by Application in 2019
Figure 36. China Deferiprone Sales Market Share by Company in 2019
Figure 37. China Deferiprone Sales Market Share by Type in 2019
Figure 38. China Deferiprone Sales Market Share by Application in 2019
Figure 39. Japan Deferiprone Sales Market Share by Company in 2019
Figure 40. Japan Deferiprone Sales Market Share by Type in 2019
Figure 41. Japan Deferiprone Sales Market Share by Application in 2019
Figure 42. Southeast Asia Deferiprone Sales Market Share by Company in 2019
Figure 43. Southeast Asia Deferiprone Sales Market Share by Type in 2019
Figure 44. Southeast Asia Deferiprone Sales Market Share by Application in 2019
Figure 45. India Deferiprone Sales Market Share by Company in 2019
Figure 46. India Deferiprone Sales Market Share by Type in 2019
Figure 47. India Deferiprone Sales Market Share by Application in 2019
Figure 48. Apotex Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Cipla Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Key Raw Materials Price Trend
Figure 51. Manufacturing Cost Structure of Deferiprone
Figure 52. Manufacturing Process Analysis of Deferiprone
Figure 53. Deferiprone Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Porter's Five Forces Analysis
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
デフェリプロンの世界市場 2020年：メーカー別、地域別、種類・用途別 Summary Market Overview The global Deferiprone market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 0.9% in the forecast period of 2020 to 2025 and will expected to reach USD 37 million by 2025, from USD 35 million in 2019. The Deferiprone market repor…- 鉄キレート剤の世界市場レポート2020 This report studies the Iron Chelation Drug market. The rationale behind using Iron chelation therapy is removing the increased iron burden specifically labile cell iron (LCI) to minimize production of reactive oxygen species (ROS) thereby decreasing cellular and organ damage. Patients most likely t…
- 過負荷リレーの世界市場レポート2020 Market Analysis and Insights: Global Overload Relays Market The global Overload Relays market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Overload Relays Scope and Market Size The global Overload Relays mark…
- 過負荷保護装置の世界市場レポート2020 Overload protection is a protection against a running overcurrent that would cause overheating of the protected equipment. Hence, an overload is also type of overcurrent. Overload protection typically operates on an inverse time curve where the tripping time becomes less as the current increases. Ma…
- デフェラシロックスの世界市場レポート2020 Deferasirox is an oral iron chelator. Its main use is to reduce chronic iron overload in patients who are receiving long-term blood transfusions for conditions such as beta- thalassemia and other chronic anemias. The half-life of deferasirox is between 8 and 16 hours allowing once a day dosing. Two …